AXIM BIOTECHNOLOGIES, INC. Balance Sheet
AXIM|9 years of annual SEC 10-K data (FY2011-FY2023)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
AXIM BIOTECHNOLOGIES, INC. had $4M in total assets with negative shareholders' equity of $8M as of FY2023.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $47.3K | $1.8M | $2.1M | $713.3K | $134.2K | $127 | $19.1K | $23.1K |
| Accounts Receivable | $0 | $0 | - | - | - | - | - | $20.0K | $65.0K |
| Inventory | - | - | $9.8K | $8.8K | $38.4K | $200.8K | - | - | - |
| Current Assets | $156.5K | $104.0K | $2.0M | $2.1M | $1.4M | $1.2M | $3.1K | $39.1K | $88.1K |
| PP&E (Net) | $134.1K | $93.8K | $5.6K | $8.9K | $12.3K | $15.7K | - | - | - |
| Total Assets | $4.1M | $4.2M | $2.1M | $2.2M | $1.4M | $1.3M | $56.8K | $132.8K | $137.3K |
| Current Liabilities | $6.0M | $3.4M | $3.3M | $7.7M | $3.0M | $2.5M | $150.7K | $137.5K | $127.1K |
| Shareholders' Equity | -$7.7M | -$4.8M | -$6.1M | -$6.3M | -$2.4M | -$1.7M | -$93.9K | -$4.7K | $10.2K |